Status:
RECRUITING
Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery
Lead Sponsor:
Chung-Ang University Gwangmyeong Hospital
Conditions:
Laryngeal Disease
Pharyngeal Diseases
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the effects of remimazolam and propofol on postoperative recovery time, complications, and safety in patients undergoing ambulatory upper airway surgery under g...
Detailed Description
Patients scheduled for ambulatory upper airway (including nasal cavity, oral cavity, pharynx, larynx) surgery and who agree to participate in the study will be randomly assigned to the Remimazolam gro...
Eligibility Criteria
Inclusion
- Adult patients (age 19 or older) undergoing ambulatory upper respiratory tract (nasal cavity, oral cavity, pharynx, larynx) surgery under general anesthesia
- American Society of Anesthesiologists physical class classification I, II, and III
Exclusion
- Patients who refused to participate in the study
- Pregnant patients
- Patients with a history of hypersensitivity to drugs or additives used during surgery
- Patients with acute narrow-angle glaucoma
- Alcohol or drug dependent patients
- Patients with Child-Pugh class C liver dysfunction
Key Trial Info
Start Date :
January 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 22 2025
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT06507202
Start Date
January 22 2024
End Date
March 22 2025
Last Update
July 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ChungAng University Gwangmyeong Hospital
Gyeonggi-do, Gwangmyeon-si, South Korea, 14353